FORM 8-K |
Delaware (State or Other Jurisdiction of Incorporation or Organization) | 94-2896096 (I.R.S. Employer I. D. No.) |
Exhibit | Description | |
99.1 | Press release, dated July 23, 2015 announcing the Company's preliminary financial results for the fourth quarter of fiscal year 2015, and a 7% dividend increase. |
Maxim Integrated Products, Inc. | |
By:/s/ Bruce Kiddoo | |
Bruce Kiddoo Senior Vice President and Chief Financial Officer |
Exhibit | Description | |
99.1 |
• | Revenue: $583 million |
• | Gross Margin: 52.1% GAAP (60.9% excluding special items) |
• | EPS: $0.34 GAAP ($0.43 excluding special items) |
• | Cash, cash equivalents, and short term investments: $1.63 billion |
• | Fiscal first quarter revenue outlook: $545 million to $585 million |
• | Quarterly dividend increased 7% to $0.30 per share |
• | Cash flow from operations: $222 million |
• | Net capital additions: $13 million |
• | Dividends: $80 million ($0.28 per share) |
• | Stock repurchases: $36 million |
• | Revenue: $545 million to $585 million |
• | Gross Margin: 51% to 54% GAAP (60% to 63% excluding special items) |
• | EPS: $0.22 to $0.28 GAAP ($0.38 to $0.44 excluding special items) |
CONSOLIDATED STATEMENTS OF INCOME | |||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||
Three Months Ended | Year Ended | ||||||||||||||||||||
June 27, 2015 | March 28, 2015 | June 28, 2014 | June 27, 2015 | June 28, 2014 | |||||||||||||||||
(in thousands, except per share data) | |||||||||||||||||||||
Net revenues | $ | 582,517 | $ | 577,263 | $ | 642,467 | $ | 2,306,864 | $ | 2,453,663 | |||||||||||
Cost of goods sold (1) | 278,816 | 261,995 | 273,507 | 1,034,997 | 1,068,898 | ||||||||||||||||
Gross margin | 303,701 | 315,268 | 368,960 | 1,271,867 | 1,384,765 | ||||||||||||||||
Operating expenses: | |||||||||||||||||||||
Research and development | 121,552 | 123,913 | 143,802 | 521,772 | 558,168 | ||||||||||||||||
Selling, general and administrative | 72,532 | 75,766 | 83,153 | 308,065 | 324,734 | ||||||||||||||||
Intangible asset amortization | 3,618 | 3,977 | 4,423 | 16,077 | 17,690 | ||||||||||||||||
Impairment of long-lived assets (2) | 549 | 5,522 | 6,447 | 67,042 | 11,644 | ||||||||||||||||
Impairment of goodwill and intangible assets (3) | — | — | — | 93,010 | 2,580 | ||||||||||||||||
Severance and restructuring expenses (4) | 12,798 | 2,824 | 5,790 | 30,642 | 24,902 | ||||||||||||||||
Acquisition-related costs | — | — | — | — | 6,983 | ||||||||||||||||
Other operating expenses (income), net (5) | (2,296 | ) | (2,184 | ) | 8,795 | (2,021 | ) | 15,773 | |||||||||||||
Total operating expenses | 208,753 | 209,818 | 252,410 | 1,034,587 | 962,474 | ||||||||||||||||
Operating income | 94,948 | 105,450 | 116,550 | 237,280 | 422,291 | ||||||||||||||||
Interest and other income (expense), net (6) | 28,500 | (5,534 | ) | (8,943 | ) | 8,890 | (13,065 | ) | |||||||||||||
Income before provision for income taxes | 123,448 | 99,916 | 107,607 | 246,170 | 409,226 | ||||||||||||||||
Provision (benefit) for income taxes | 24,789 | 20,483 | 22,814 | 40,132 | 54,416 | ||||||||||||||||
Net income | 98,659 | 79,433 | 84,793 | 206,038 | 354,810 | ||||||||||||||||
Earnings per share: | |||||||||||||||||||||
Basic | $ | 0.35 | $ | 0.28 | $ | 0.30 | $ | 0.73 | $ | 1.25 | |||||||||||
Diluted | $ | 0.34 | $ | 0.28 | $ | 0.29 | $ | 0.71 | $ | 1.23 | |||||||||||
Shares used in the calculation of earnings per share: | |||||||||||||||||||||
Basic | 284,202 | 283,418 | 283,431 | 283,675 | 283,344 | ||||||||||||||||
Diluted | 289,346 | 288,840 | 289,487 | 288,949 | 289,108 | ||||||||||||||||
Dividends paid per share | $ | 0.28 | $ | 0.28 | $ | 0.26 | $ | 1.12 | $ | 1.04 | |||||||||||
SCHEDULE OF SPECIAL ITEMS | |||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||
Three Months Ended | Year Ended | ||||||||||||||||||||
June 27, 2015 | March 28, 2015 | June 28, 2014 | June 27, 2015 | June 28, 2014 | |||||||||||||||||
(in thousands) | |||||||||||||||||||||
Cost of goods sold: | |||||||||||||||||||||
Intangible asset amortization | $ | 18,116 | $ | 18,750 | $ | 18,750 | $ | 74,366 | $ | 64,483 | |||||||||||
Accelerated Depreciation (1) | 32,765 | 9,834 | — | 51,494 | — | ||||||||||||||||
Acquisition-related inventory write-up | — | — | 371 | — | 18,955 | ||||||||||||||||
Total | $ | 50,881 | $ | 28,584 | $ | 19,121 | $ | 125,860 | $ | 83,438 | |||||||||||
Operating expenses: | |||||||||||||||||||||
Intangible asset amortization | $ | 3,618 | $ | 3,977 | $ | 4,423 | $ | 16,077 | $ | 17,690 | |||||||||||
Impairment of long-lived assets (2) | 549 | 5,522 | 6,447 | 67,042 | 11,644 | ||||||||||||||||
Impairment of goodwill and intangible assets (3) | — | — | — | 93,010 | 2,580 | ||||||||||||||||
Severance and restructuring (4) | 12,798 | 2,824 | 5,790 | 30,642 | 24,902 | ||||||||||||||||
Acquisition-related costs | — | — | — | — | 6,983 | ||||||||||||||||
Other operating expenses (income), net (5) | (2,296 | ) | (2,184 | ) | 8,795 | (2,021 | ) | 15,773 | |||||||||||||
Total | $ | 14,669 | $ | 10,139 | $ | 25,455 | $ | 204,750 | $ | 79,572 | |||||||||||
Interest and other expense (income), net (6) | $ | (35,849 | ) | $ | — | $ | 2,432 | $ | (36,066 | ) | $ | 6,155 | |||||||||
Total | $ | (35,849 | ) | $ | — | $ | 2,432 | $ | (36,066 | ) | $ | 6,155 | |||||||||
Provision (benefit) for income taxes: | |||||||||||||||||||||
Fixed assets tax basis adjustment (7) | $ | — | $ | — | $ | (1,041 | ) | $ | — | $ | (35,603 | ) | |||||||||
Reversal of tax reserves (8) | — | — | — | (21,747 | ) | — | |||||||||||||||
Fiscal year 2014 research & development tax credits | — | — | — | (2,863 | ) | $ | — | ||||||||||||||
Total | $ | — | $ | — | $ | (1,041 | ) | $ | (24,610 | ) | $ | (35,603 | ) | ||||||||
(1) Includes accelerated depreciation related to San Jose wafer manufacturing building and equipment. | |||||||||||||||||||||
(2) Includes impairment charges relating to wafer manufacturing equipment, end of line test equipment, and software. | |||||||||||||||||||||
(3) Impairment of goodwill and write-off of in-process research and development primarily related to MEMS business. | |||||||||||||||||||||
(4) Includes severance charges primarily associated with the reorganization of various business units and manufacturing operations. | |||||||||||||||||||||
(5) Other operating expenses (income), net are primarily for legal settlements, loss (gain) relating to sale of assets, and expected loss on lease abandonment. | |||||||||||||||||||||
(6) Includes sale of a business and impairment of investment in privately-held companies. | |||||||||||||||||||||
(7) Includes one-time fixed asset tax basis adjustments relating to prior year depreciation expense. | |||||||||||||||||||||
(8) Reversal of tax reserves related to the favorable settlement of a foreign tax issue. | |||||||||||||||||||||
CONSOLIDATED BALANCE SHEETS | |||||||||||||
(Unaudited) | |||||||||||||
June 27, 2015 | March 28, 2015 | June 28, 2014 | |||||||||||
(in thousands) | |||||||||||||
ASSETS | |||||||||||||
Current assets: | |||||||||||||
Cash and cash equivalents | $ | 1,550,965 | $ | 1,392,197 | $ | 1,322,472 | |||||||
Short-term investments | 75,154 | 75,142 | 49,953 | ||||||||||
Total cash, cash equivalents and short-term investments | 1,626,119 | 1,467,339 | 1,372,425 | ||||||||||
Accounts receivable, net | 278,844 | 278,427 | 295,828 | ||||||||||
Inventories | 288,474 | 297,270 | 289,292 | ||||||||||
Deferred tax assets | 77,306 | 71,354 | 74,597 | ||||||||||
Other current assets | 49,838 | 66,298 | 54,560 | ||||||||||
Total current assets | 2,320,581 | 2,180,688 | 2,086,702 | ||||||||||
Property, plant and equipment, net | 1,090,739 | 1,155,589 | 1,331,519 | ||||||||||
Intangible assets, net | 261,652 | 283,385 | 360,994 | ||||||||||
Goodwill | 511,647 | 511,824 | 596,637 | ||||||||||
Other assets | 43,765 | 36,231 | 29,766 | ||||||||||
TOTAL ASSETS | $ | 4,228,384 | $ | 4,167,717 | $ | 4,405,618 | |||||||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||||
Current liabilities: | |||||||||||||
Accounts payable | $ | 88,322 | $ | 85,361 | $ | 102,076 | |||||||
Income taxes payable | 34,779 | 20,102 | 20,065 | ||||||||||
Accrued salary and related expenses | 181,360 | 163,354 | 186,732 | ||||||||||
Accrued expenses | 48,389 | 55,967 | 64,028 | ||||||||||
Deferred income on shipments to distributors | 30,327 | 30,550 | 25,734 | ||||||||||
Total current liabilities | 383,177 | 355,334 | 398,635 | ||||||||||
Long-term debt | 1,000,000 | 1,000,000 | 1,001,026 | ||||||||||
Income taxes payable | 410,378 | 385,838 | 362,802 | ||||||||||
Deferred tax liabilities | 90,588 | 116,284 | 159,879 | ||||||||||
Other liabilities | 54,221 | 56,412 | 53,365 | ||||||||||
Total liabilities | 1,938,364 | 1,913,868 | 1,975,707 | ||||||||||
Stockholders' equity: | |||||||||||||
Common stock | 283 | 12,359 | 285 | ||||||||||
Additional paid-in capital | 27,859 | — | 23,005 | ||||||||||
Retained earnings | 2,279,112 | 2,260,011 | 2,423,794 | ||||||||||
Accumulated other comprehensive loss | (17,234 | ) | (18,521 | ) | (17,173 | ) | |||||||
Total stockholders' equity | 2,290,020 | 2,253,849 | 2,429,911 | ||||||||||
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY | $ | 4,228,384 | $ | 4,167,717 | $ | 4,405,618 | |||||||
CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||
Three Months Ended | Year Ended | ||||||||||||||||||||
June 27, 2015 | March 28, 2015 | June 28, 2014 | June 27, 2015 | June 28, 2014 | |||||||||||||||||
(in thousands) | |||||||||||||||||||||
Cash flows from operating activities: | |||||||||||||||||||||
Net income | $ | 98,659 | $ | 79,433 | $ | 84,793 | $ | 206,038 | $ | 354,810 | |||||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||||||||
Stock-based compensation | 17,709 | 18,586 | 21,786 | 79,491 | 85,452 | ||||||||||||||||
Depreciation and amortization | 92,639 | 71,439 | 64,391 | 299,396 | 244,593 | ||||||||||||||||
Deferred taxes | (32,207 | ) | (15,658 | ) | (9,501 | ) | (72,507 | ) | (32,159 | ) | |||||||||||
Loss (gain) from sale of property, plant and equipment | (1,228 | ) | (441 | ) | 1,068 | 419 | 2,187 | ||||||||||||||
Tax benefit (shortfall) related to stock-based compensation | (861 | ) | 7,635 | 942 | 8,155 | (68 | ) | ||||||||||||||
Impairment of long-lived assets | 517 | 5,522 | 6,447 | 67,010 | 11,644 | ||||||||||||||||
Impairment of investments in privately-held companies | 94 | — | 6,537 | 94 | 10,260 | ||||||||||||||||
In-process research and development written-off | — | — | — | 8,900 | 2,580 | ||||||||||||||||
Loss (gain) on sale of business | (35,849 | ) | — | — | (35,849 | ) | — | ||||||||||||||
Impairment of goodwill | — | — | — | 84,110 | — | ||||||||||||||||
Excess tax benefit from stock-based compensation | (2,372 | ) | (5,997 | ) | (4,897 | ) | (12,549 | ) | (14,192 | ) | |||||||||||
Changes in assets and liabilities: | |||||||||||||||||||||
Accounts receivable | (417 | ) | (19,921 | ) | 8,300 | 16,984 | 13,340 | ||||||||||||||
Inventories | 10,105 | 9,194 | 1,226 | 2,163 | 20,672 | ||||||||||||||||
Other current assets | 15,338 | (156 | ) | 26,579 | (8,783 | ) | 45,557 | ||||||||||||||
Accounts payable | 2,874 | 477 | 5,203 | (4,201 | ) | (11,255 | ) | ||||||||||||||
Income taxes payable | 39,217 | 22,587 | 9,853 | 62,350 | 54,492 | ||||||||||||||||
Deferred revenue on shipments to distributors | (223 | ) | 3,447 | 1,475 | 4,593 | (823 | ) | ||||||||||||||
All other accrued liabilities | 17,793 | 5,917 | 9,882 | (12,110 | ) | (10,983 | ) | ||||||||||||||
Net cash provided by (used in) operating activities | 221,788 | 182,064 | 234,084 | 693,704 | 776,107 | ||||||||||||||||
Cash flows from investing activities: | |||||||||||||||||||||
Payments for property, plant and equipment | (15,360 | ) | (10,185 | ) | (23,654 | ) | (75,816 | ) | (132,523 | ) | |||||||||||
Proceeds from sales of property, plant and equipment | 2,741 | 1,615 | 1,627 | 29,035 | 5,293 | ||||||||||||||||
Proceeds from sale of business | 35,550 | — | — | 35,550 | — | ||||||||||||||||
Proceeds from maturity of available-for-sale securities | — | — | — | — | 27,000 | ||||||||||||||||
Purchases of available-for-sale securities | — | — | (49,953 | ) | (25,142 | ) | (49,953 | ) | |||||||||||||
Purchases of privately-held companies securities | — | (200 | ) | — | (200 | ) | — | ||||||||||||||
Payments in connection to acquisitions | — | — | — | — | (459,256 | ) | |||||||||||||||
Proceeds from sales of investments of privately-held companies | — | 500 | — | 500 | — | ||||||||||||||||
Net cash provided by (used in) investing activities | 22,931 | (8,270 | ) | (71,980 | ) | (36,073 | ) | (609,439 | ) | ||||||||||||
Cash flows from financing activities: | |||||||||||||||||||||
Excess tax benefit from stock-based compensation | 2,372 | 5,997 | 4,897 | 12,549 | 14,192 | ||||||||||||||||
Contingent consideration paid | — | — | — | — | (4,705 | ) | |||||||||||||||
Dividends paid | (79,558 | ) | (79,419 | ) | (73,626 | ) | (317,909 | ) | (294,175 | ) | |||||||||||
Repayment of notes payable | — | — | (2,430 | ) | (437 | ) | (4,708 | ) | |||||||||||||
Issuance of debt | — | — | — | — | 497,895 | ||||||||||||||||
Debt issuance cost | — | — | — | — | (3,431 | ) | |||||||||||||||
Repurchase of common stock | (35,963 | ) | (36,774 | ) | (40,744 | ) | (195,088 | ) | (305,314 | ) | |||||||||||
Issuance of ESPP shares under employee stock purchase program | 22,298 | — | 23,713 | 40,951 | 42,809 | ||||||||||||||||
Net issuance of restricted stock units | (7,428 | ) | (8,369 | ) | (8,922 | ) | (30,657 | ) | (31,384 | ) | |||||||||||
Proceeds from stock options exercised | 12,328 | 31,098 | 26,232 | 61,453 | 69,639 | ||||||||||||||||
Net cash provided by (used in) financing activities | (85,951 | ) | (87,467 | ) | (70,880 | ) | (429,138 | ) | (19,182 | ) | |||||||||||
Net increase (decrease) in cash and cash equivalents | 158,768 | 86,327 | 91,224 | 228,493 | 147,486 | ||||||||||||||||
Cash and cash equivalents: | |||||||||||||||||||||
Beginning of period | 1,392,197 | 1,305,870 | 1,231,248 | 1,322,472 | 1,174,986 | ||||||||||||||||
End of period | $ | 1,550,965 | $ | 1,392,197 | $ | 1,322,472 | $ | 1,550,965 | $ | 1,322,472 | |||||||||||
Total cash, cash equivalents and short-term investments | $ | 1,626,119 | $ | 1,467,339 | $ | 1,372,425 | $ | 1,626,119 | $ | 1,372,425 | |||||||||||
ANALYSIS OF GAAP VERSUS GAAP EXCLUDING SPECIAL ITEMS DISCLOSURES | ||||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||||
Three Months Ended | Year Ended | |||||||||||||||||||||
June 27, 2015 | March 28, 2015 | June 28, 2014 | June 27, 2015 | June 28, 2014 | ||||||||||||||||||
(in thousands, except per share data) | ||||||||||||||||||||||
Reconciliation of GAAP gross profit to GAAP gross profit excluding special items: | ||||||||||||||||||||||
GAAP gross profit | $ | 303,701 | $ | 315,268 | $ | 368,960 | $ | 1,271,867 | $ | 1,384,765 | ||||||||||||
GAAP gross profit % | 52.1 | % | 54.6 | % | 57.4 | % | 55.1 | % | 56.4 | % | ||||||||||||
Special items: | ||||||||||||||||||||||
Intangible asset amortization | 18,116 | 18,750 | 18,750 | 74,366 | 64,483 | |||||||||||||||||
Accelerated Depreciation (1) | 32,765 | 9,834 | — | 51,494 | — | |||||||||||||||||
Acquisition-related inventory write-up | — | — | 371 | — | 18,955 | |||||||||||||||||
Total special items | 50,881 | 28,584 | 19,121 | 125,860 | 83,438 | |||||||||||||||||
GAAP gross profit excluding special items | $ | 354,582 | $ | 343,852 | $ | 388,081 | $ | 1,397,727 | $ | 1,468,203 | ||||||||||||
GAAP gross profit % excluding special items | 60.9 | % | 59.6 | % | 60.4 | % | 60.6 | % | 59.8 | % | ||||||||||||
Reconciliation of GAAP operating expenses to GAAP operating expenses excluding special items: | ||||||||||||||||||||||
GAAP operating expenses | $ | 208,753 | $ | 209,818 | $ | 252,410 | $ | 1,034,587 | $ | 962,474 | ||||||||||||
Special items: | ||||||||||||||||||||||
Intangible asset amortization | 3,618 | 3,977 | 4,423 | 16,077 | 17,690 | |||||||||||||||||
Impairment of long-lived assets (2) | 549 | 5,522 | 6,447 | 67,042 | 11,644 | |||||||||||||||||
Impairment of goodwill and intangible assets (3) | — | — | — | 93,010 | 2,580 | |||||||||||||||||
Severance and restructuring (4) | 12,798 | 2,824 | 5,790 | 30,642 | 24,902 | |||||||||||||||||
Acquisition-related costs | — | — | — | — | 6,983 | |||||||||||||||||
Other operating expenses (income), net (5) | (2,296 | ) | (2,184 | ) | 8,795 | (2,021 | ) | 15,773 | ||||||||||||||
Total special items | 14,669 | 10,139 | 25,455 | 204,750 | 79,572 | |||||||||||||||||
GAAP operating expenses excluding special items | $ | 194,084 | $ | 199,679 | $ | 226,955 | $ | 829,837 | $ | 882,902 | ||||||||||||
Reconciliation of GAAP net income to GAAP net income excluding special items: | ||||||||||||||||||||||
GAAP net income | $ | 98,659 | $ | 79,433 | $ | 84,793 | $ | 206,038 | $ | 354,810 | ||||||||||||
Special items: | ||||||||||||||||||||||
Intangible asset amortization | 21,734 | 22,727 | 23,173 | 90,443 | 82,173 | |||||||||||||||||
Accelerated Depreciation (1) | 32,765 | 9,834 | — | 51,494 | — | |||||||||||||||||
Acquisition-related inventory write-up | — | — | 371 | — | 18,955 | |||||||||||||||||
Impairment of long-lived assets (2) | 549 | 5,522 | 6,447 | 67,042 | 11,644 | |||||||||||||||||
Impairment of goodwill and intangible assets (3) | — | — | — | 93,010 | 2,580 | |||||||||||||||||
Severance and restructuring (4) | 12,798 | 2,824 | 5,790 | 30,642 | 24,902 | |||||||||||||||||
Acquisition-related costs | — | — | — | — | 6,983 | |||||||||||||||||
Other operating expenses (income), net (5) | (2,296 | ) | (2,184 | ) | 8,795 | (2,021 | ) | 15,773 | ||||||||||||||
Interest and other expense, net (6) | (35,849 | ) | — | 2,432 | (36,066 | ) | 6,155 | |||||||||||||||
Pre-tax total special items | 29,701 | 38,723 | 47,008 | 294,544 | 169,165 | |||||||||||||||||
Tax effect of special items | (4,267 | ) | (3,910 | ) | (6,850 | ) | (35,333 | ) | (19,383 | ) | ||||||||||||
Fixed asset tax basis adjustment (7) | — | — | (1,041 | ) | — | (35,603 | ) | |||||||||||||||
Reversal of tax reserves (8) | — | — | — | (21,747 | ) | — | ||||||||||||||||
Fiscal year 2014 research & development tax credits | — | — | — | (2,863 | ) | — | ||||||||||||||||
GAAP net income excluding special items | $ | 124,093 | $ | 114,246 | $ | 123,910 | $ | 440,639 | $ | 468,989 | ||||||||||||
GAAP net income per share excluding special items: | ||||||||||||||||||||||
Basic | $ | 0.44 | $ | 0.40 | $ | 0.44 | $ | 1.55 | $ | 1.66 | ||||||||||||
Diluted | $ | 0.43 | $ | 0.40 | $ | 0.43 | $ | 1.52 | $ | 1.62 | ||||||||||||
Shares used in the calculation of earnings per share excluding special items: | ||||||||||||||||||||||
Basic | 284,202 | 283,418 | 283,431 | 283,675 | 283,344 | |||||||||||||||||
Diluted | 289,346 | 288,840 | 289,487 | 288,949 | 289,108 | |||||||||||||||||
(1) Includes accelerated depreciation related to San Jose wafer manufacturing building and equipment. | ||||||||||||||||||||||
(2) Includes impairment charges relating to wafer manufacturing equipment, end of line test equipment, and software. | ||||||||||||||||||||||
(3) Impairment of goodwill and write-off of in-process research and development primarily related to MEMS business. | ||||||||||||||||||||||
(4) Includes severance charges primarily associated with the reorganization of various business units and manufacturing operations. | ||||||||||||||||||||||
(5) Other operating expenses (income), net are primarily for legal settlements, loss (gain) relating to sale of assets, and expected loss on lease abandonment. | ||||||||||||||||||||||
(6) Includes sale of a business and impairment of investment in privately-held companies. | ||||||||||||||||||||||
(7) Includes one-time fixed asset tax basis adjustments relating to prior year depreciation expense. | ||||||||||||||||||||||
(8) Reversal of tax reserves related to the favorable settlement of a foreign tax issue. | ||||||||||||||||||||||